Skip to main content
An official website of the United States government

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Evans Williams, Felicia, M.B.A.
felicia.evanslong@nih.gov
240-276-5076
5E636 Program Analyst | Cancer Biomarkers
Fu, Sidney, M.D.
sidney.fu@nih.gov
240-276-6669
5E134 Program Officer | Cancer Biomarkers
Hodges, Nicholas, Ph.D.
nick.hodges@nih.gov
240-276-7844
5E616 Program Officer | Cancer Biomarkers
Kohaar, Indu, Ph.D., M.Phil., M.Sc.
indu.kohaar@nih.gov
240-620-0875
5E612 Program Officer | Cancer Biomarkers
Krueger, Karl, Ph.D. [V]
karl.krueger@nih.gov
Volunteer | Cancer Biomarkers
Marquez, Guillermo, Ph.D.
guillermo.marquez@nih.gov
240-276-7035
5E132 Program Officer | Cancer Biomarkers
Orr, Susan
susan.orr@nih.gov
240-276-5001
5E626 Program Support Assistant | Cancer Biomarkers
Patriotis, Christos, Ph.D., M.Sc.
christos.patriotis@nih.gov
240-276-7134
5E614 Deputy Chief | Cancer Biomarkers
Petruzzelli, Angie
angie.petruzzelli@nih.gov
240-276-5076
5E624 Program Support Assistant | Cancer Biomarkers
Srivastava, Sudhir, Ph.D., M.P.H.
sudhir.srivastava@nih.gov
240-276-7028
5E136 Chief | Cancer Biomarkers
Villanueva, Juan Miguel
juan.villanueva@nih.gov
5E630 Program Analyst | Cancer Biomarkers
Wang, Wendy, Ph.D., M.Sc.
wendy.wang@nih.gov
240-276-7117
5E566 Program Officer | Cancer Biomarkers
Young, Matthew, Ph.D.
matthew.young@nih.gov
240-276-5846
5E610 Program Officer | Cancer Biomarkers

Grants

PI Name PI Organization Title Sort descending Grant Number Program Official
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-03 Christos Patriotis, Ph.D., M.Sc.
Zhang, Zhen

Johns Hopkins University
United States

A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach 5U2CCA271891-04 Christos Patriotis, Ph.D., M.Sc.
Rosser, Charles J

Cedars-Sinai Medical Center
United States

A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology 5R01CA277810-03 Guillermo Marquez, Ph.D.
Alambeigi, Farshid

University Of Texas At Austin
United States

A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps 5R21CA280747-02 Matthew Young, Ph.D.
Skubitz, Amy Patrice

University Of Minnesota
United States

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection 5R01CA262153-05 Christos Patriotis, Ph.D., M.Sc.
Cocucci, Emanuele

Ohio State University
United States

A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL 5R01CA270251-04 Matthew Young, Ph.D.
Huang, Ying

Fred Hutchinson Cancer Center
United States

Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies 5R01CA277133-04 Matthew Young, Ph.D.
Wei, Lei

Roswell Park Cancer Institute Corp
United States

Advancing skin cancer prevention by tackling UV-induced clonogenic mutations 5R01CA255242-05 Wendy Wang, Ph.D., M.Sc.
Lin, Jia-Ren

Harvard Medical School
United States

Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images 5R50CA274277-04 Guillermo Marquez, Ph.D.
Wildman-Tobriner, Benjamin

Duke University
United States

AI for Differentiation of Low vs High Risk Thyroid Nodules on Ultrasound 1R01CA297227-01A1 Wendy Wang, Ph.D., M.Sc.
Wolpin, Brian Matthew

Dana-Farber Cancer Inst
United States

Altered metabolism and machine learning for pancreatic cancer early detection 5U01CA210171-09 Matthew Young, Ph.D.
Huang, Yijian

Emory University
United States

Analytic diagnosis methods for disease ruling 5R01CA283687-02 Guillermo Marquez, Ph.D.
Lyden, David Charles

Weill Medical Coll Of Cornell Univ
United States

Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection 5R01CA218513-08 Matthew Young, Ph.D.
Saenger, Yvonne Margaret

Albert Einstein College Of Medicine
United States

Applying pathomics to establish a biosignature for aggressive skin melanoma 5R01CA260375-05 Guillermo Marquez, Ph.D.
Frazier, Anne Lindsay

Dana-Farber Cancer Inst
United States

Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors 5UH3CA240688-05 Nicholas Hodges, Ph.D.